|
|
|
11-50 employees
View all
|
|
Biotechnology
|
|
632 Russel St, Covington, KY 41011, US
|
|
Bexion Pharmaceuticals is a mid-stage clinical company developing life-changing treatments in Oncology and CNS. The company’s lead compound, BXQ-350, is a novel S1P modulator. With our highly experienced biotech leadership team and expertise in Oncology, we are urgently progressing our pipeline to develop life-changing oncology therapies on our path to becoming a leading biotech/pharmaceutical company.
To learn more about Bexion Pharmaceuticals, please visit Bexionpharma.com or contact Margaret van Gilse at (859) 446-7386 or [email protected].
|
Bexion Pharmaceuticals Email Formats | Example Email Formats | Percentage |
---|---|---|
{f}{last} | [email protected] |
100%
|
The widely used Bexion Pharmaceuticals email format is {f}{last} (e.g. [email protected]) with 100% adoption across the company.
To contact Bexion Pharmaceuticals customer service number call here 859-446-7386. To contact Bexion Pharmaceuticals customer service number in your country click here to find.
Ray Takigiku is the CEO of Bexion Pharmaceuticals. To contact Ray Takigiku email at [email protected].
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.